KISUNLA- donanemab-azbt injection, solution

Eli Lilly-Specialty

KISUNLA is an amyloid beta-directed antibody indicated for the treatment of Alzheimer’s disease. Treatment with KISUNLA should be initiated in patients with mild cognitive impairment or mild dementia stage of disease, the population in which treatment was initiated in the clinical trials. (1)

Unopened Vial

Store refrigerated at 2°C to 8°C (36°F to 46°F).
Keep the vial in the outer carton to protect from light.
Do not freeze or shake.
If refrigeration is not available, may be stored at room temperature (20°C to 25°C [68°F to 77°F]) for up to 3 days.